2004
DOI: 10.1007/s00213-004-1806-x
|View full text |Cite
|
Sign up to set email alerts
|

Administration of eliprodil during ethanol withdrawal in the neonatal rat attenuates ethanol-induced learning deficits

Abstract: These data support the hypothesis that NMDA receptor-mediated excitotoxicity during ethanol withdrawal contributes to fetal alcohol effects.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

5
55
0

Year Published

2007
2007
2014
2014

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 41 publications
(60 citation statements)
references
References 41 publications
5
55
0
Order By: Relevance
“…PNEE increases fetal levels of glutamate (Karl et al, 1995) and administration of an NMDAR antagonist following PNEE can rescue ethanol-induced deficits in offspring spatial memory (Thomas et al, 2004). These studies suggest that heightened NMDAR activity due to ethanol-induced increases in glutamate might also contribute to ethanol toxicity.…”
Section: Discussionmentioning
confidence: 97%
“…PNEE increases fetal levels of glutamate (Karl et al, 1995) and administration of an NMDAR antagonist following PNEE can rescue ethanol-induced deficits in offspring spatial memory (Thomas et al, 2004). These studies suggest that heightened NMDAR activity due to ethanol-induced increases in glutamate might also contribute to ethanol toxicity.…”
Section: Discussionmentioning
confidence: 97%
“…Given the wide range of actions of agmatine throughout the CNS, it is possible that the protection observed in our study was partly based on some of these additional mechanisms, independent of NMDAR modulation. However, additional behavioral work from our laboratory and others (Thomas et al, 2004), using more specific NR2B or polyamine antagonists, as well as cell culture studies specifically examining the effects of agmatine and polyamines on glutamate-induced cell death (Gibson et al, 2003) favor an NMDAR/polyamine modulation hypothesis.…”
Section: Discussionmentioning
confidence: 99%
“…Although the side effects of MK-801 preclude its use clinically, success in animal models of early ethanol exposure has generated interest in alternate NMDAR antagonists that may be more viable. At least three types of antagonists seem particularly promising; low-affinity, non-competitive NMDAR channel blockers such as memantine (Volbracht et al, 2006), which is currently used clinically for treating Alzheimer's disease, NR2B subunit antagonists such as ifenprodil or eliprodil (Nikam & Meltzer, 2002;Thomas et al, 2004), and agents that modulate rather than block NMDAR activity such as agmatine, which can act at the polyamine binding site, resulting in allosteric modulation of the receptor.…”
Section: Introductionmentioning
confidence: 99%
“…[4,5]) and/or pharmacological treatments (e.g. [6][7][8]) of FASD and mechanisms of alcohol-induced damage (e.g. [9,10]).…”
Section: Introductionmentioning
confidence: 99%